INS and Hypoglycemia: Qualitative research shows that people with type 1 diabetes increasingly expect closed-loop systems to be able to cope with atypical scenarios.8, -10 In response, some closed-loop systems, such as the CamAPS FX app, now include a personalizable user-initiated mode of operation, activation of which notifies the algorithm that insulin requirements are higher for a user-defined time period.11 This has the potential to improve usability, increase time in range, and reduce risk of hypoglycemia associated with standard manual correction doses.